Evidence Linking Some Fluoroquinolones to Uveitis GrowsEvidence Linking Some Fluoroquinolones to Uveitis Grows
Moxifloxacin or ciprofloxacin appear to increase the risk for uveitis; levofloxacin less so. Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 7, 2014 Category: Infectious Diseases Tags: Internal Medicine News Source Type: news
Moxifloxacin Struggles Against Current TB Drugs: REMox TrialMoxifloxacin Struggles Against Current TB Drugs: REMox Trial
Although a shorter, moxifloxacin-containing regimen did not measure up to standard tuberculosis therapy, the drug shows promise, experts say. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2014 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
4-Drug Combo May Reduce TB Therapy Time
BOSTON (MedPage Today) -- Substituting rifapentine (Priftin) and moxifloxacin (Avelox) for two of four standard drugs may reduce the time necessary to treat patients infected with tuberculosis, researchers reported here. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 10, 2014 Category: Primary Care Source Type: news
Dr Reddy's launches antibiotic drug in US market
According to IMS Health, Avelox (moxifloxacin HCl) tablets had a sales figure of approximately USD 195 millions in 2013, the release said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2014 Category: Pharmaceuticals Source Type: news
Treatment of Infections Due to Resistant Staphylococcus aureus
This chapter reviews data on the treatment of infections caused by drug-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA). This review covers findings reported in the English language medical literature up to January of 2013. Despite the emergence of resistant and multidrug-resistant S. aureus, we have seven effective drugs in clinical use for which little resistance has been observed: vancomycin, quinupristin–dalfopristin, linezolid, tigecycline, telavancin, ceftaroline, and daptomycin. However, vancomycin is less effective for infections with MRSA isolates that have a higher MIC w...
Source: Springer protocols feed by Microbiology - October 6, 2013 Category: Microbiology Source Type: news
Fluoroquinolones Up Risk for Severe Dysglycemia in DiabetesFluoroquinolones Up Risk for Severe Dysglycemia in Diabetes
Use of fluoroquinolones, in particular moxifloxacin, appears to increase the risk of severe blood glucose swings in patients with diabetes compared with the use of other classes of antibiotic. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Certain Antibiotics Tied to Blood Sugar Swings in Diabetics
Drugs such as Cipro, Avelox were most implicated, but experts say other factors may be at play
Source: HealthDay
Related MedlinePlus Pages: Antibiotics, Blood Sugar, Diabetes (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 15, 2013 Category: Consumer Health News Source Type: news
Study examines risk of severe blood sugar swings among diabetics taking fluoroquinolones
(Infectious Diseases Society of America) Diabetic patients taking oral fluoroquinolones, a frequently prescribed class of antibiotics, were found to have a higher risk of severe blood sugar-related problems than diabetic patients taking other kinds of antibiotics, according to a recent study from Taiwan published in Clinical Infectious Diseases. The increased risk was low, but clinicians should consider the higher risk when treating diabetic patients with fluoroquinolones, especially moxifloxacin, and prescribe them cautiously, the study's authors concluded. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2013 Category: Global & Universal Source Type: news
Risk Of Kidney Disease Doubled With Use Of Fluoroquinolone Antibiotics
The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a study of published in CMAJ (Canadian Medical Association Journal). Fluoroquinolones, including ciprofloxacin, levofloxacin and moxifloxacin, are common broad-spectrum antibiotics most often used to treat respiratory and urogenital infections. Case reports have indicated acute kidney injury with use, and prescription labels carry a warning of kidney failure. However, when oral fluoroquinolones are prescribed in clinical practice, kidney injury is usually not considered... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news
Moxifloxacin versus ciprofloxacin plus co-amoxiclav for fever in low-risk neutropoenic patients with cancer
Source: Journal of Clinical Oncology
Area: News
According to the results of a double-blind RCT, monotherapy with once daily oral moxifloxacin is associated with similar efficacy to ciprofloxacin plus co-amoxiclav combination therapy in the treatment of fever in adults with cancer and neutropoenia who are deemed to be at low-risk of complications.
The authors note that prompt empirical antibiotic therapy for fever in patients with neutropenia has become the standard of care; current guidelines recommend oral ciprofloxacin plus co-amoxiclav as the standard regimen for those who are low-risk. The purpose of the c...
Source: NeLM - News - January 29, 2013 Category: Drugs & Pharmacology Source Type: news
